IRVINE, Calif., Feb. 14, 2017 -- InMode welcomes Mr. Shakil Lakhani, Executive Vice President of Sales, North America. Mr. Lakhani has been in the industry for over a decade, bringing a vast amount of experience with him. He began his career in 2006 with one of the largest aesthetic laser companies, Cynosure Inc., as the youngest Territory Manager, and was quickly promoted to Area Sales Manager and Sales Director by 2013. He has experienced rapid growth throughout his career and attributes the majority of his success to his upbringing and support from his family. Mr. Lakhani graduated with a B.A. from the University of Waterloo.
Mr. Tyler Lembke joins the InMode team as Vice President of Sales for the West Region. With more than 11 years of experience in the medical and aesthetic laser industry, Mr. Lembke has held various sales and management positions for Cynosure, Cutera, and Lumenis. Most recently Mr. Lembke has specialized in the introduction and rapid launch of innovative niche technologies into the marketplace. Mr. Lembke graduated with a Bachelor of Science in Business from Oklahoma State University.
Adrian Bishop is appointed as Vice President of Sales for the East Region. Previously, Mr. Bishop served as Director of Sales, Southeast Region for Syneron-Candela. He was the Top Producing Director of Sales for both fiscal year 2015 and fiscal 2016 for Syneron breaking sales records both years. He also held many sales and training roles with Syneron Candela as well as Solta Medical prior to that. Mr. Bishop has a proven track record of building award winning sales teams and will continue that momentum at InMode. Mr. Bishop received a B.S.B.A. in Marketing and Business Administration from Christian Brothers University in Memphis TN.
“InMode is very excited about the growth opportunities brought by our new executive team. Coupled with our outstanding technology, this improved sales structure will further strengthen our presence in the aesthetic market,” says Erik Dowell, CEO of Americas.
About InMode Aesthetics
InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser, and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode/Invasix technologies by visiting www.inmodemd.com.
Contact: Yang Phan Vice-President of Marketing for North America [email protected] | 1.855.411.2639 x3


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



